Indonesia
· Delayed Price · Currency is IDR IDX:MEDS Statistics
Total Valuation
IDX:MEDS has a market cap or net worth of IDR 78.13 billion. The enterprise value is 82.43 billion.
| Market Cap | 78.13B |
| Enterprise Value | 82.43B |
Important Dates
The last earnings date was Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IDX:MEDS has 1.56 billion shares outstanding. The number of shares has increased by 0.73% in one year.
| Current Share Class | 1.56B |
| Shares Outstanding | 1.56B |
| Shares Change (YoY) | +0.73% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 76.24% |
| Owned by Institutions (%) | n/a |
| Float | 371.29M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.20 |
| PB Ratio | 1.42 |
| P/TBV Ratio | 1.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -8.79 |
| EV / Sales | 24.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -313.84 |
Financial Position
The company has a current ratio of 2.25, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.25 |
| Quick Ratio | 0.63 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | -17.33 |
| Interest Coverage | -20.09 |
Financial Efficiency
Return on equity (ROE) is -15.75% and return on invested capital (ROIC) is -9.13%.
| Return on Equity (ROE) | -15.75% |
| Return on Assets (ROA) | -8.64% |
| Return on Invested Capital (ROIC) | -9.13% |
| Return on Capital Employed (ROCE) | -16.73% |
| Revenue Per Employee | 187.10M |
| Profits Per Employee | -520.94M |
| Employee Count | 18 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.43 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.96 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 50.00 |
| 200-Day Moving Average | 51.53 |
| Relative Strength Index (RSI) | 40.16 |
| Average Volume (20 Days) | 38,755 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, IDX:MEDS had revenue of IDR 3.37 billion and -9.38 billion in losses. Loss per share was -5.98.
| Revenue | 3.37B |
| Gross Profit | -1.13B |
| Operating Income | -9.57B |
| Pretax Income | -9.11B |
| Net Income | -9.38B |
| EBITDA | -5.41B |
| EBIT | -9.57B |
| Loss Per Share | -5.98 |
Balance Sheet
The company has 243.36 million in cash and 4.55 billion in debt, giving a net cash position of -4.31 billion or -2.76 per share.
| Cash & Cash Equivalents | 243.36M |
| Total Debt | 4.55B |
| Net Cash | -4.31B |
| Net Cash Per Share | -2.76 |
| Equity (Book Value) | 54.83B |
| Book Value Per Share | 35.06 |
| Working Capital | 9.31B |
Cash Flow
In the last 12 months, operating cash flow was -99.18 million and capital expenditures -163.48 million, giving a free cash flow of -262.66 million.
| Operating Cash Flow | -99.18M |
| Capital Expenditures | -163.48M |
| Free Cash Flow | -262.66M |
| FCF Per Share | -0.17 |
Margins
Gross margin is -33.42%, with operating and profit margins of -284.06% and -278.43%.
| Gross Margin | -33.42% |
| Operating Margin | -284.06% |
| Pretax Margin | -270.61% |
| Profit Margin | -278.43% |
| EBITDA Margin | -160.73% |
| EBIT Margin | -284.06% |
| FCF Margin | n/a |
Dividends & Yields
IDX:MEDS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.73% |
| Shareholder Yield | -0.73% |
| Earnings Yield | -12.00% |
| FCF Yield | -0.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |